You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

791 Results
Drug
Other Name(s): Lederle Leucovorin® (multiple brands available)
Apr 2019
Drug
Other Name(s): Sandostatin® (multiple brands available) , Sandostatin® LAR™ (Novartis)
Aug 2016
Drug
Other Name(s): Lupron® , Lupron Depot® , Eligard®
May 2025
Drug
Other Name(s): CeeNU®
Aug 2024
Drug
Other Name(s): Gazyva®
May 2022
Drug
Other Name(s): Lenvima®
Sep 2023
Drug
Other Name(s): Somatuline® Autogel®
Jun 2024
Drug
Other Name(s): Tagrisso®
Jan 2024
Drug
Other Name(s): Onivyde® (Baxalta Canada)
Sep 2017
Regimen
Intent: Adjuvant
Funding:
ODB - General Benefit
    letrozole
Aug 2025
Regimen
Intent: Palliative
Funding:
ODB - General Benefit
    letrozole
Aug 2025
Regimen
Cancer Type:
Hematologic, 
Myelodysplastic Syndrome (MDS)
Intent: Palliative
Funding:
ODB Limited Use
    lenalidomide - For the treatment of patients with anemia due to myelodysplastic syndrome (MDS), according to clinical criteria
May 2022

Pages